Christopher G Smith

10PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersMedical virologyMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 13, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay.

|Apr 15, 2025
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

Milou M F Schuurbiers, Christopher G Smith, Koen J Hartemink

|May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma.

Alaa Embaby, Sanne C F A Huijberts, Liqin Wang

|Sep 28, 2022
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework.

Sabrina H Rossi, Izzy Newsham, Sara Pita

|Jun 23, 2022
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).

Grant D Stewart, Sarah J Welsh, Stephan Ursprung

|Dec 21, 2021
Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.

Irena Hudecova, Christopher G Smith, Robert Hänsel-Hertsch

Pageof 2

Frequent Collaborators

5 joint publications

Nitzan Rosenfeld

5 joint publications

Grant D Stewart

4 joint publications

Florent Mouliere

4 joint publications

Dineika Chandrananda